Patents Assigned to Cirius Therapeutics, Inc.
  • Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases
    Patent number: 11931345
    Abstract: Provided herein are thiazolidinedione analogues that are useful for treating non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), diabetes, and other metabolic inflammation-mediated disease and disorders.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: March 19, 2024
    Assignee: Cirius Therapeutics, Inc.
    Inventor: Gerard R. Colca